Morten A Nielsen

Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA

T. Theander, P. Scaria, A. Salanti, 2023, Lab animal.

First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2

H. Wertheim, J. Bukh, S. Justesen, 2023, The Lancet Microbe.

Molecular properties and diagnostic potential of monoclonal antibodies targeting cytotoxic α-synuclein oligomers

G. Krainer, A. Sander, J. Nowak, 2024, NPJ Parkinson's disease.